@article{4db011e9389742c08f7575d62fee0fd7,
title = "A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD)",
abstract = "Female sexual arousal disorder (FSAD) is a condition that can affect women of all ages and have a significant negative impact on emotional well-being.",
author = "Miguel Orri and Lucy Abraham and Annamaria Giraldi",
note = "{\textcopyright} 2013 International Society for Sexual Medicine.",
year = "2013",
month = oct,
doi = "10.1111/jsm.12071",
language = "English",
volume = "10",
pages = "2484--96",
journal = "The journal of sexual medicine",
issn = "1743-6095",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "10",
}